Company
ChinaShenzhen Hepalink Pharmaceutical Group Co., Ltd., Shenzhen, China – FDA Inspections
Inspection records and compliance data for Shenzhen Hepalink Pharmaceutical Group Co., Ltd. in Shenzhen. 1 FDA inspection on record, 1 Form 483, last inspected June 13, 2025.
Company Profile
This profile covers Shenzhen Hepalink Pharmaceutical Group Co., Ltd. based in Shenzhen, China.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 1
- Warning letters
- 0
Inspected June 13, 2025.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| June 13, 2025 | Not classified | Human Drugs | 1276175 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Tien (Tianjin) Pharmaceutical Co., Ltd.
Guangdong Blue Treasure Pharmaceuticals Co. Ltd.
BrightGene Pharmaceutical Co., Ltd.
Suzhou Lixin Pharmaceutical Co. Ltd.
Esteve Huayi Pharmaceutical Co., Ltd.
Qingdao Jiulong Biopharmaceutical Co. Ltd.
Shandong Lixin Pharmaceutical Co., Ltd.
NANJING HAIRUN PHARMACEUTICAL CO., LTD.
Qilu Pharmaceutical Co., Ltd. (Laoling Site)
Erregierre S.p.A.
Company Information
Name
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
FEI Number
3014772595
Address
No. 1 Rongtian Road, Longgang District, Shenzhen, China
Country
China
ID: b23022d9-a3c3-493b-87c3-9c00c755fdbf